O Neil Global Advisors Inc. Buys Shares of 21,203 Aspen Aerogels, Inc. (NYSE:ASPN)

O Neil Global Advisors Inc. acquired a new position in shares of Aspen Aerogels, Inc. (NYSE:ASPN) during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 21,203 shares of the construction company’s stock, valued at approximately $506,000.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Worth Venture Partners LLC grew its holdings in Aspen Aerogels by 2.9% during the 4th quarter. Worth Venture Partners LLC now owns 440,988 shares of the construction company’s stock valued at $6,959,000 after buying an additional 12,621 shares during the last quarter. AIGH Capital Management LLC grew its holdings in shares of Aspen Aerogels by 3.0% during the fourth quarter. AIGH Capital Management LLC now owns 1,804,484 shares of the construction company’s stock worth $28,475,000 after buying an additional 52,462 shares in the last quarter. Banque Cantonale Vaudoise lifted its stake in shares of Aspen Aerogels by 37.5% during the first quarter. Banque Cantonale Vaudoise now owns 4,593 shares of the construction company’s stock valued at $81,000 after buying an additional 1,252 shares during the period. Harbour Capital Advisors LLC purchased a new position in shares of Aspen Aerogels during the 1st quarter worth $404,000. Finally, Assenagon Asset Management S.A. acquired a new stake in shares of Aspen Aerogels during the first quarter worth $636,000. 97.64% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several brokerages have recently weighed in on ASPN. Benchmark reiterated a “buy” rating and set a $14.00 price objective on shares of Aspen Aerogels in a report on Thursday, August 8th. Roth Mkm reaffirmed a “buy” rating and set a $36.00 price target on shares of Aspen Aerogels in a research report on Wednesday, August 21st. Piper Sandler increased their price target on Aspen Aerogels from $30.00 to $36.00 and gave the company an “overweight” rating in a report on Wednesday, May 29th. TD Cowen raised their target price on Aspen Aerogels from $36.00 to $41.00 and gave the company a “buy” rating in a report on Tuesday, August 20th. Finally, Barclays assumed coverage on shares of Aspen Aerogels in a report on Tuesday, August 6th. They set an “overweight” rating and a $27.00 price target for the company. One analyst has rated the stock with a sell rating, nine have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $29.70.

Aspen Aerogels Stock Performance

Shares of ASPN opened at $24.84 on Friday. Aspen Aerogels, Inc. has a 12-month low of $5.94 and a 12-month high of $33.15. The business’s fifty day moving average price is $24.81 and its 200 day moving average price is $22.90. The company has a debt-to-equity ratio of 0.23, a current ratio of 3.46 and a quick ratio of 2.82. The stock has a market capitalization of $1.91 billion, a PE ratio of -56.45 and a beta of 2.16.

Aspen Aerogels (NYSE:ASPN) last announced its quarterly earnings results on Wednesday, August 7th. The construction company reported $0.21 EPS for the quarter, beating the consensus estimate of $0.05 by $0.16. The company had revenue of $117.80 million for the quarter, compared to analyst estimates of $101.99 million. Aspen Aerogels had a net margin of 0.39% and a return on equity of 0.74%. Aspen Aerogels’s revenue was up 144.4% compared to the same quarter last year. During the same quarter last year, the business earned ($0.22) earnings per share. Equities research analysts forecast that Aspen Aerogels, Inc. will post 0.21 EPS for the current year.

Insider Buying and Selling at Aspen Aerogels

In other news, CFO Ricardo C. Rodriguez sold 32,465 shares of the business’s stock in a transaction on Monday, August 26th. The stock was sold at an average price of $30.14, for a total value of $978,495.10. Following the sale, the chief financial officer now owns 20,790 shares of the company’s stock, valued at approximately $626,610.60. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 4.30% of the stock is owned by corporate insiders.

Aspen Aerogels Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.